Matsunaga, Kazuto http://orcid.org/0000-0002-0514-3241
Yoshida, Yuri
Makita, Naoyuki
Nishida, Kenichiro
Rhodes, Kirsty
Nordon, Clementine
Funding for this research was provided by:
AstraZeneca K.K.
Article History
Received: 18 April 2024
Accepted: 5 June 2024
First Online: 8 July 2024
Declarations
:
: Kazuto Matsunaga received lecture fees from AstraZeneca, Sanofi, Chugai, GSK, Novartis Pharma, Kyorin Pharmaceutical, and Boehringer Ingelheim. Yuri Yoshida is an employee of AstraZeneca. Naoyuki Makita is an employee of AstraZeneca. Kenichiro Nishida is an employee of AstraZeneca. Kirsty Rhodes is an employee of AstraZeneca and holds shares or stock/stock options in AstraZeneca. Clementine Nordon is an employee of AstraZeneca and holds shares or stock/stock options in AstraZeneca.
: This study was conducted according to the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects. As the data for this study were extracted from a commercially available de-identified claims database, informed consent was not required. The protocol of this study and any amendments were approved in writing by the MINS Research Ethics Committee (MINS-REC220211; 7 April 2022). Permission was obtained to access and use the data from the MDV database.